KHDRBS3 promotes multi‐drug resistance and anchorage‐independent growth in colorectal cancer

5‐Fluorouracil (5‐FU) is one of the most frequently used pharmacological agents in the treatment of colorectal cancer (CRC). Resistance to chemotherapy is a major cause of treatment failure of CRC, and it is a well known fact that cancer stem cells play a significant role in the acquisition of drug...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Sci
Päätekijät: Ukai, Shoichi, Sakamoto, Naoya, Taniyama, Daiki, Harada, Kenji, Honma, Ririno, Maruyama, Ryota, Naka, Kazuhito, Hinoi, Takao, Takakura, Yuji, Shimizu, Wataru, Ohdan, Hideki, Yasui, Wataru
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7935809/
https://ncbi.nlm.nih.gov/pubmed/33423358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14805
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia